Inventor profile of:

Dalia Megiddo

City:

Nataf

Country:

Israel

Published Applications:

21

Last publication date:

2026-01-15

Top Assignees for applications by Dalia Megiddo

The entities that hold a legal rights for patent applications filed by inventor Megiddo Dalia:

Recent patent applications by Megiddo Dalia

Dalia Megiddo from Nataf, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-15
US20260014072A1
Human necessities

TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE

#2 | 2025-07-31
US20250241936A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER

#3 | 2024-01-11
US20240009113A1
Human necessities

Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose

#4 | 2022-09-15
US20220288096A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER

#5 | 2022-04-21
US20220117883A1
Human necessities

TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE

#6 | 2021-01-14
US20210008089A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER

#7 | 2019-12-12
US20190374463A1
Human necessities

Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose

#8 | 2019-11-07
US20190336518A1
Human necessities

Compositions and methods for treating an aggregation disease or disorder

#9 | 2017-01-26
US20170020905A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER

#10 | 2016-07-14
US20160199362A1
Human necessities

METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION

#11 | 2016-07-07
US20160193199A1
Human necessities

Methods of treating fragile X syndrome and related disorders

#12 | 2016-05-05
US20160120798A1
Human necessities

Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose

#13 | 2016-04-14
US20160101122A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SPINOCEREBELLAR ATAXIA

#14 | 2016-01-28
US20160022716A1
Human necessities

Compositions and methods for treating huntington's disease

#15 | 2015-11-19
US20150328247A1
Human necessities

Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin

#16 | 2015-07-16
US20150196575A1
Human necessities

Compositions and methods for treating spinocerebellar ataxia

#17 | 2015-01-22
US20150025111A1
Chemistry; metallurgy

Substituted pyridoxine-lactam carboxylate-salts

#18 | 2014-11-13
US20140336145A1
Human necessities

Compositions and methods for treating oculopharyngeal muscular dystrophy

#19 | 2013-03-07
US20130059887A1
Chemistry; metallurgy

Substituted pyridoxine-lactam carboxylate salts

#20 | 2012-10-18
US20120264781A1
Human necessities

METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION

#21 | 2011-12-01
US20110294859A1
Chemistry; metallurgy

SUBSTITUTED PYRIDOXINE-LACTAM CARBOXYLATE SALTS

InventorID:

129120 ⎘